Immunotherapy for hepatocellular carcinoma: The challenge of biomarker studies
J Chin Med Assoc
.
2021 Feb 1;84(2):121-122.
doi: 10.1097/JCMA.0000000000000458.
Author
I-Cheng Lee
1
2
Affiliations
1
Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
2
Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.
PMID:
33177399
DOI:
10.1097/JCMA.0000000000000458
No abstract available
Publication types
Editorial
Comment
MeSH terms
Biomarkers
Carcinoma, Hepatocellular* / therapy
Humans
Immunologic Factors
Immunotherapy
Liver Neoplasms* / therapy
Substances
Biomarkers
Immunologic Factors